Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells.
暂无分享,去创建一个
[1] A. Domb,et al. Hydrogel probe for iontophoresis drug delivery to the eye , 2004, Journal of biomaterials science. Polymer edition.
[2] L. Rossetti,et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.
[3] J. Mazzola,et al. Subcellular localization of human glyceraldehyde-3-phosphate dehydrogenase is independent of its glycolytic function. , 2003, Biochimica et biophysica acta.
[4] Hitoshi Takahashi,et al. Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[5] D. Chuang,et al. Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington’s disease , 2003, Molecular and Cellular Neuroscience.
[6] J. Mazzola,et al. Subcellular alteration of glyceraldehyde‐3‐phosphate dehydrogenase in Alzheimer's disease fibroblasts , 2003, Journal of neuroscience research.
[7] C. Gerhardinger,et al. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. , 2003, Diabetes.
[8] D. Puro,et al. Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. , 2002, Investigative ophthalmology & visual science.
[9] W. Tatton,et al. Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. , 2002, The Journal of pharmacology and experimental therapeutics.
[10] S. Mohr,et al. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. , 2002, Diabetes.
[11] Johan Gabrielsson,et al. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications , 2002 .
[12] Y. Ikada,et al. Hydrogels for Biomedical and Pharmaceutical Applications , 2001 .
[13] C. Gerhardinger,et al. Early cellular and molecular changes induced by diabetes in the retina , 2001, Diabetologia.
[14] H. Schmitz. Reversible nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase upon serum depletion. , 2001, European journal of cell biology.
[15] J. Dreyer,et al. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. , 2001, Journal of cell science.
[16] N. Tatton. Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease , 2000, Experimental Neurology.
[17] D. Puro,et al. Energy metabolism in human retinal Müller cells. , 2000, Investigative ophthalmology & visual science.
[18] N. Davies,et al. Biopharmaceutical Considerations In Topical Ocular Drug Delivery , 2000, Clinical and experimental pharmacology & physiology.
[19] A. Boulton,et al. Glyceraldehyde‐3‐phosphate dehydrogenase and apoptosis , 2000, Journal of neuroscience research.
[20] M A Sirover,et al. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. , 1999, Biochimica et biophysica acta.
[21] C. Siganos,et al. The distribution of gentamicin in the rabbit cornea following iontophoresis to the central cornea. , 1999, Journal of Ocular Pharmacology and Therapeutics.
[22] J. Fang,et al. Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model. , 1999, International journal of pharmaceutics.
[23] S. Sealfon,et al. Nuclear translocation of GAPDH-GFP fusion protein during apoptosis. , 1999, Neuroreport.
[24] B. Brüne,et al. Nitric Oxide-induced S-Glutathionylation and Inactivation of Glyceraldehyde-3-phosphate Dehydrogenase* , 1999, The Journal of Biological Chemistry.
[25] D. Chuang,et al. Nuclear Translocation of Glyceraldehyde‐3‐Phosphate Dehydrogenase Isoforms During Neuronal Apoptosis , 1999, Journal of neurochemistry.
[26] T. Gardner,et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. , 1998, The Journal of clinical investigation.
[27] E. Lapetina,et al. Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[28] D. Chuang,et al. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. , 1998, Molecular pharmacology.
[29] P. Fürst,et al. Glyceraldehyde-3-phosphate Dehydrogenase, the Putative Target of the Antiapoptotic Compounds CGP 3466 andR-(−)-Deprenyl* , 1998, The Journal of Biological Chemistry.
[30] C. Gerhardinger,et al. Müller cell changes in human diabetic retinopathy. , 1998, Diabetes.
[31] D. Chuang,et al. Subcellular Distribution of Glyceraldehyde‐3‐Phosphate Dehydrogenase in Cerebellar Granule Cells Undergoing Cytosine Arabinoside‐Induced Apoptosis , 1997, Journal of neurochemistry.
[32] S. Snyder,et al. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Sirover. Role of the glycolytic protein, glyceraldehyde‐3‐phosphate dehydrogenase, in normal cell function and in cell pathology , 1997, Journal of cellular biochemistry.
[34] J. Robinson,et al. Ocular pharmacokinetics/pharmacodynamics , 1997 .
[35] D. Nicolau,et al. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. , 1997, The Journal of antimicrobial chemotherapy.
[36] O. Manor,et al. Efficacy of iontophoresis in the rat cornea , 1996, Graefe's Archive for Clinical and Experimental Ophthalmology.
[37] E. Newman,et al. The Müller cell: a functional element of the retina , 1996, Trends in Neurosciences.
[38] M. Lorenzi,et al. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. , 1996, The Journal of clinical investigation.
[39] D. Chuang,et al. Evidence that Glyceraldehyde‐3‐Phosphate Dehydrogenase Is Involved in Age‐Induced Apoptosis in Mature Cerebellar Neurons in Culture , 1996, Journal of neurochemistry.
[40] Hiroshi Takahashi,et al. Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain , 1995, Neuroscience Letters.
[41] J. P. Frangie. Clinical Pharmacokinetics of Various Topical Ophthalmic Delivery Systems , 1995, Clinical pharmacokinetics.
[42] W. Craig. Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA , 1995, European Journal of Clinical Microbiology and Infectious Diseases.
[43] S. Crawford,et al. National Survey of Once‐Daily Dosing of Aminoglycoside Antibiotics , 1995, Pharmacotherapy.
[44] Yie W. Chien,et al. Hydrogel-Based lontotherapeutic Delivery Devices for Transdermal Delivery of Peptide/Protein Drugs , 1993, Pharmaceutical Research.
[45] M. Brin,et al. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. , 1993, The New England journal of medicine.
[46] T. Mano,et al. Modulation of calcium channels in human retinal glial cells by basic fibroblast growth factor: a possible role in retinal pathobiology , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[47] R. Grossman,et al. Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis. , 1990, Investigative ophthalmology & visual science.
[48] W. George,et al. Topical vs systemic gentamicin penetration into the human cornea and aqueous humor. , 1987, Archives of ophthalmology.
[49] J. Blaser,et al. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance , 1987, Antimicrobial Agents and Chemotherapy.
[50] J. Baum,et al. Transscleral iontophoresis of gentamicin in monkeys. , 1987, Investigative ophthalmology & visual science.
[51] J. Rissing,et al. Iontophoresis of vidarabine monophosphate for herpes orolabialis. , 1986, The Journal of infectious diseases.
[52] D. Maurice,et al. A fresh look at iontophoresis. , 1984, Archives of ophthalmology.
[53] J. Rissing,et al. Iontophoresis of gentamicin into aphakic rabbit eyes. Sustained vitreal levels. , 1984, Investigative ophthalmology & visual science.
[54] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[55] L. Gangarosa,et al. Practical considerations in iontophoresis of fluoride for desensitizing dentin. , 1978, The Journal of prosthetic dentistry.
[56] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[57] R E COOKE,et al. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. , 1959, Pediatrics.
[58] G. Erlanger. Iontophoresis, a scientific and practical tool in ophthalmology. , 1954, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[59] W. Tatton,et al. Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. , 2000, Molecular pharmacology.
[60] W. Tatton,et al. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. , 2000, Journal of neural transmission. Supplementum.
[61] W. Craig. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] J. Crabb,et al. Establishment and characterization of a retinal Müller cell line. , 1998, Investigative ophthalmology & visual science.
[63] R. Schoenwald. Ocular drug delivery. Pharmacokinetic considerations. , 1990, Clinical pharmacokinetics.
[64] J. Baum,et al. Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit. , 1986, Ophthalmology.
[65] J M Graham,et al. A device for iontophoretic anaesthesia of the tympanic membrane. , 1982, Journal of medical engineering & technology.
[66] P. Ellis. Ocular therapeutics and pharmacology , 1977 .
[67] E. Selinger. Iontophoresis with contract lens type and eyecup electrodes some points of the theory and technic of ion transfer. , 1947, A M A Archives of Ophthalmology.